- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Supernus Pharmaceuticals Inc+ Add to Watchlist
SUPN:US6.6500 USD 0.0500 0.76%
As of 17:20:00 ET on 05/23/2013.
Company Profile for Supernus Pharmaceuticals Inc (SUPN)
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company develops and markets proprietary drugs for the treatment of central nervous system diseases and disorders. Supernus has developed a portfolio of clinical stage drugs to address neurological and psychological problems such as epilepsy, conduct disorder, Parkinson's disease, ADHD, depression and anxiety.
Supernus Pharmaceuticals Inc
Key Executives for Supernus Pharmaceuticals Inc (SUPN)
|Jack A KhattarPresident/CEO/Secy/Founder||Stefan K F SchwabeExec VP:R&D/Chief Medical Ofcr|
|Padmanabh P Bhatt PhdSenior VP:Intellectual Property||Victor VaughnSenior VP:Sales|
|Gregory S PatrickVP/CFO||Jones W Bryan "Woody"VP:Business Development & Proj|
|Tammy T MartinVP:Regulatory Affairs|